Unlocking the True Potential of Decentralized Clinical Trials

April 17, 2022
Unlocking the True Potential of Decentralized Clinical Trials

Covid -19 outbreak has helped in growing the magnitude of decentralized clinical trials, transforming the world as we know it today.

Here in this blog, we will discuss how decentralized clinical trial management is going to reshape the future of clinical operations, what are the advantages, and which technological tools are being used to engage with subjects all over the world.

But first, let’s understand Decentralized Clinical Trials in brief.

What Are Decentralized Clinical Trials?

The clinical trials are executed without requiring the patient to be there physically at the central site. The process is done using telemedicine, local healthcare providers, and technological tools that are different from traditional clinical trials. It’s a relatively new concept that has gained a lot of traction in recent years, especially during the pandemic, and is interestingly relevant in the post-pandemic world.

The Upside of Decentralized Clinical Trial Research Management

With the expanded reach, the sponsors can now recruit subjects from across the world in a cost-effective way. They don’t need to spend more money on building infrastructure, patient scheduling, and streamlining the hospitalization operations. 

On the other hand, the participants can also save on transportation costs while using the extra time to generate income.

Since the Electronic Clinical Trial Management System (eCTMS) ensures the transmission of data in real-time, sponsors and investigators don’t need to wait for the results, they can instantly see it.

How Decentralization is Reshaping the Future of Clinical Trial Research Management?

There are many decentralized clinical trial management systems out there that are not only the best at responsibly aggregating data, but also leveraging the right technology to transform this data into actionable insights to drive better outcomes and superior user experiences.

In this new world of decentralized clinical trials (DCTs), one of the major challenges we all might face is to have multiple access points and massive amounts of data flowing through one platform. 

However, the adoption of smart wearables and a myriad of intake channels such as in-person visits, virtual meetings or consultations, online questionnaires, remote monitoring devices, and electronic health records (EHRs), has helped us with increased frequency and volume of data captured at the patient level. 

By transferring the complete focus toward the participants and their care team, the overall experience of clinical trial management can be changed. A more approachable trial should be created appealing to a broader and more diverse participant pool that is the perfect reflection of society. 

This is definitely a good thing to improve the quality of clinical research management. 

With technological advancements on the rise, decentralized clinical trials can surely accommodate advanced algorithms in AI & ML to transform patient interaction in good ways. The next decade offers a promising future for a patient-centric ecosystem just like the electronic clinical trial management system. 

Build a decentralized trial management system, contact us today https://cloudester.com/contact-us/